Valuation — not yet established
No valuation for NanoPharmaceuticals is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($6.6M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for NanoPharmaceuticals
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2025 | Seed Round | $623K | ▮ | ▮ |
| Aug 2018 | Seed Round | $1.3M | ▮ | ▮ |
| Apr 2017 | Seed Round | $2.0M | ▮ | ▮ |
| Nov 2013 | Seed Round | $2.6M | ▮ | ▮ |
How NanoPharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For NanoPharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has NanoPharmaceuticals raised?
- NanoPharmaceuticals has raised $6.6M in total funding across 4 recorded rounds.
- When did NanoPharmaceuticals last raise?
- NanoPharmaceuticals last raised in Jan 2025 (Seed Round), raising $623K.